FDA clears Abbott's cholesterol medicine TriLipix

Abbott Laboratories secured FDA clearance to market TriLipix, a cholesterol drug that can be used alone or with statins to manage lipid problems. TriLipix contains the active ingredient in the firm's TriCor, a blockbuster cholesterol medication that will start losing patent protection in 2011.

View Full Article in:

Wall Street Journal, The · Daily Herald (Arlington Heights, Ill.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA